Apigenin enhances the cisplatin cytotoxic effect through p53-modulated apoptosis

Oncology Letters

Volumn 13, Issue 2, 2017, Pages 1024-1030

  Liu, Rui ^a   Ji, Ping ^b   Liu, Bin ^a   Qiao, Haishi ^b   Wang, Xia ^a   Zhou, Likun ^a   Deng, Ting ^a   Ba, Yi ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Apigenin; Apoptosis; Cancer; Cisplatin; p53

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; APIGENIN; CASPASE 3; CASPASE 9; CISPLATIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; GENE EXPRESSION; HUMAN; HUMAN CELL; MTT ASSAY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 85007297099     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2016.5495     Document Type: Article

References (48)

1. Afzal M, Safer AM and Menon M: Green tea polyphenols and their potential role in health and disease. Inflammopharmacology 23: 151-161, 2015.
2. Altemimi A, Watson DG, Kinsel M and Lightfoot DA: Simultaneous extraction, optimization, and analysis of flavonoids and polyphenols from peach and pumpkin extracts using a TLC-densitometric method. Chem Cent J 9: 39, 2015.
3. Shukla S and Gupta S: Apigenin: A promising molecule for cancer prevention. Pharm Res 27: 962-978, 2010.
4. Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, Griel AE and Etherton TD: Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer. Am J Med 113 (Suppl 9B): 71S-88S, 2002.
5. Yang S, Zhang H, Yang X, Zhu Y and Zhang M: Evaluation of antioxidative and antitumor activities of extracted flavonoids from Pink Lady apples in human colon and breast cancer cell lines. Food Funct 6: 3789-3798, 2015.
6. Trudel D, Labb� DP, Bairati I, Fradet V, Bazinet L and T�tu B: Green tea for ovarian cancer prevention and treatment: A systematic review of the in vitro, in vivo and epidemiological studies. Gynecol Oncol 126: 491-498, 2012.
7. Gupta SC, Kannappan R, Reuter S, Kim JH and Aggarwal BB: Chemosensitization of tumors by resveratrol. Ann N Y Acad Sci 1215: 150-160, 2011.
8. Nessa MU, Beale P, Chan C, Yu JQ and Huq F: Synergism from combinations of cisplatin and oxaliplatin with quercetin and thymoquinone in human ovarian tumour models. Anticancer Res 31: 3789-3797, 2011.
9. Patel D, Shukla S and Gupta S: Apigenin and cancer chemoprevention: Progress, potential and promise (review). Int J Oncol 30: 233-245, 2007.
10. Torkin R, Lavoie JF, Kaplan DR and Yeger H: Induction of caspase-dependent, p53-mediated apoptosis by apigenin in human neuroblastoma. Mol Cancer Ther 4: 1-11, 2005.
11. Ruela-de-Sousa RR, Fuhler GM, Blom N, Ferreira CV, Aoyama H and Peppelenbosch MP: Cytotoxicity of apigenin on leukemia cell lines: Implications for prevention and therapy. Cell Death Dis 1: e19, 2010.
12. Horinaka M, Yoshida T, Shiraishi T, Nakata S, Wakada M and Sakai T: The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand. Mol Cancer Ther 5: 945-951, 2006.
13. Strouch MJ, Milam BM, Melstrom LG, McGill JJ, Salabat MR, Ujiki MB, Ding XZ and Bentrem DJ: The flavonoid apigenin potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells. Pancreas 38: 409-415, 2009.
14. Xu Y, Xin Y, Diao Y, Lu C, Fu J, Luo L and Yin Z: Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells. PLoS One 6: e29169, 2011.
15. Angelini A, Di Ilio C, Castellani ML, Conti P and Cuccurullo F: Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin-resistant sarcoma cells (MES-SA/DX-5): Implications for natural sedatives as chemosensitizing agents in cancer therapy. J Biol Regul Homeost Agents 24: 197-205, 2010.
16. Choi EJ and Kim GH: 5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells. Oncol Rep 22: 1533-1537, 2009.
17. Wong IL, Chan KF, Tsang KH, Lam CY, Zhao Y, Chan TH and Chow LM: Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives. J Med Chem 52: 5311-5322, 2009.
18. Cai X and Liu X: Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damage. Proc Natl Acad Sci USA 105: 16958-16963, 2008.
19. Chabner BA and Roberts TG Jr,: Timeline: Chemotherapy and the war on cancer. Nat Rev Cancer 5: 65-72, 2005.
20. Billecke C, Finniss S, Tahash L, Miller C, Mikkelsen T, Farrell NP and B�gler O: Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma. Neuro Oncol 8: 215-226, 2006.
21. Mendes F, Groessl M, Nazarov AA, Tsybin YO, Sava G, Santos I, Dyson PJ and Casini A: Metal-based inhibition of poly (ADP-ribose) polymerase-the guardian angel of DNA. J Med Chem 54: 2196-2206, 2011.
22. Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M and Kroemer G: Molecular mechanisms of cisplatin resistance. Oncogene 31: 1869-1883, 2012.
23. Dhandapani KM, Mahesh VB and Brann DW: Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFκB transcription factors. J Neurochem 102: 522-538, 2007.
24. Li Z, Musich PR and Zou Y: Differential DNA damage responses in p53 proficient and deficient cells: Cisplatin-induced nuclear import of XPA is independent of ATR checkpoint in p53-deficient lung cancer cells. Int J Biochem Mol Biol 2: 138-145, 2011.
25. Losert D, Pratscher B, Soutschek J, Geick A, Vornlocher HP, M�ller M and Wacheck V: Bcl-2 downregulation sensitizes nonsmall cell lung cancer cells to cisplatin, but not to docetaxel. Anticancer Drugs 18: 755-761, 2007.
26. He F, Wang Q, Zheng XL, Yan JQ, Yang L, Sun H, Hu LN, Lin Y and Wang X: Wogonin potentiates cisplatin-induced cancer cell apoptosis through accumulation of intracellular reactive oxygen species. Oncol Rep 28: 601-605, 2012.
27. Chen X, Wang Z, Yang Z, Wang J, Xu Y, Tan RX and Li E: Houttuynia cordata blocks HSV infection through inhibition of NF-κB activation. Antiviral Res 92: 341-345, 2011.
28. Yang Z, Lee J, Ahn HJ, Chong CK, Dias RF and Nam HW: Western Blot Detection of Human Anti-Chikungunya Virus Antibody with Recombinant Envelope 2 Protein. Korean J Parasitol 54: 239-241, 2016.
29. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
30. Lin DL and Chang C: p53 is a mediator for radiation-repressed human TR2 orphan receptor expression in MCF-7 cells, a new pathway from tumor suppressor to member of the steroid receptor superfamily. J Biol Chem 271: 14649-14652, 1996.
31. Stindt MH, Muller PA, Ludwig RL, Kehrloesser S, D�tsch V and Vousden KH: Functional interplay between MDM2, p63/p73 and mutant p53. Oncogene 34: 4300-4310, 2015.
32. Heyne K, F�rster J, Sch�le R and Roemer K: Transcriptional repressor NIR interacts with the p53-inhibiting ubiquitin ligase MDM2. Nucleic Acids Res 42: 3565-3579, 2014.
33. Ahn HJ, Kim KS, Shin KW, Lim KH, Kim JO, Lee JY, Kim J, Park JH, Yang KM, Baek KH, et al: Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and-independent proteasomal degradation pathways in breast cancer cells.Oncotarget 6: 44523-44537, 2015.
34. Zhao Z, Wu L, Shi H and Wu C: p53 N-terminal binding and stabilisation by PIAS3 inhibits MDM2-induced p53 ubiquitination and regulates cell growth. Mol Med Rep 9: 1903-1908, 2014.
35. Wang L, Wang L, Zhang S, Qu G, Zhang D, Li S and Liu S: Downregulation of ubiquitin E3 ligase TNF receptor-associated factor 7 leads to stabilization of p53 in breast cancer. Oncol Rep 29: 283-287, 2013.
36. Kitamura T, Fukuyo Y, Inoue M, Horikoshi NT, Shindoh M, Rogers BE, Usheva A and Horikoshi N: Mutant p53 disrupts the stress MAPK activation circuit induced by ASK1-dependent stabilization of Daxx. Cancer Res 69: 7681-7688, 2009.
37. Cui C, Wang P, Cui N, Song S, Liang H and Ji A: Sulfated polysaccharide isolated from the sea cucumber Stichopus japonicas promotes the SDF-1α/CXCR4 axis-induced NSC migration via the PI3K/Akt/FOXO3a, ERK/MAPK, and NF-κB signaling pathways. Neurosci Lett 616: 57-64, 2016.
38. Kim B, Jung N, Lee S, Sohng JK and Jung HJ: Apigenin Inhibits Cancer Stem Cell-Like Phenotypes in Human Glioblastoma Cells via Suppression of c-Met Signaling. Phytother Res 30: 1833-1840, 2016.
39. Seo HS, Ku JM, Choi HS, Woo JK, Jang BH, Go H, Shin YC and Ko SG: Apigenin induces caspase-dependent apoptosis by inhibiting signal transducer and activator of transcription 3 signaling in HER2-overexpressing SKBR3 breast cancer cells.Mol Med Rep 12: 2977-2984, 2015.
40. Cho Y, Gorina S, Jeffrey PD and Pavletich NP: Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science 265: 346-355, 1994.
41. Vazquez A, Bond EE, Levine AJ and Bond GL: The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov 7: 979-987, 2008.
42. Vucic D, Dixit VM and Wertz IE: Ubiquitylation in apoptosis: A post-translational modification at the edge of life and death. Nat Rev Mol Cell Biol 12: 439-452, 2011.
43. Meek DW: Tumour suppression by p53: A role for the DNA damage response? Nat Rev Cancer 9: 714-723, 2009.
44. Guo H, Kong S, Chen W, Dai Z, Lin T, Su J, Li S, Xie Q, Su Z, Xu Y and Lai X: Apigenin mediated protection of OGD-evoked neuron-like injury in differentiated PC12 cells. Neurochem Res 39: 2197-2210, 2014.
45. Gazzani G, Daglia M and Papetti A: Food components with anticaries activity. Curr Opin Biotechnol 23: 153-159, 2012.
46. Tang D, Chen K, Huang L and Li J: Pharmacokinetic properties and drug interactions of apigenin, a natural flavone. Expert Opin Drug Metab Toxicol 2: 1-8, 2016.
47. Chen L and Zhao W: Apigenin protects against bleomycin-induced lung fibrosis in rats. Exp Ther Med 11: 230-234, 2016.
48. Gates MA, Vitonis AF, Tworoger SS, Rosner B, Titus-Ernstoff L, Hankinson SE and Cramer DW: Flavonoid intake and ovarian cancer risk in a population-based case-control study. Int J Cancer 124: 1918-1925, 2009.